Rusan Pharma Ltd is a global pharmaceutical company specialising in addiction and pain management treatments. The company manufactures and markets a wide range of active pharmaceutical ingredients (APIs) and finished formulations, with a particular focus on controlled substances, including narcotics and psychotropics. Their facilities are GMP-approved by regulatory bodies such as the USFDA, Health Canada, EU, TGA, ANVISA, PIC/S, WHO, Russia, and SAHPRA. Rusan Pharma holds CEP approvals for APIs such as Buprenorphine, Fentanyl, Naltrexone, and Methadone, and also manufactures Naloxone, Nalbuphine, Apomorphine, as well as transdermal patches and long-acting formulations.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Finished Dosage Forms

Rusan Pharma Ltd is committed to providing innovative solutions in the pharmaceutical industry. For more information, please visit rusanpharma.com.